134 related articles for article (PubMed ID: 31822650)
1. The Na+/K+ ATPase Inhibitor Ouabain Attenuates Stemness and Chemoresistance of Osteosarcoma Cells.
Guo W; Wei B; Cheng T; Xu X; Ruan F; Xiang M
Med Sci Monit; 2019 Dec; 25():9426-9434. PubMed ID: 31822650
[TBL] [Abstract][Full Text] [Related]
2. Ouabain impairs cell migration, and invasion and alters gene expression of human osteosarcoma U-2 OS cells.
Shih YL; Au MK; Liu KL; Yeh MY; Lee CH; Lee MH; Lu HF; Yang JL; Wu RS; Chung JG
Environ Toxicol; 2017 Nov; 32(11):2400-2413. PubMed ID: 28795476
[TBL] [Abstract][Full Text] [Related]
3. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
[TBL] [Abstract][Full Text] [Related]
4. Ouabain Induces Apoptotic Cell Death Through Caspase- and Mitochondria-dependent Pathways in Human Osteosarcoma U-2 OS Cells.
Chou WH; Liu KL; Shih YL; Chuang YY; Chou J; Lu HF; Jair HW; Lee MZ; Au MK; Chung JG
Anticancer Res; 2018 Jan; 38(1):169-178. PubMed ID: 29277770
[TBL] [Abstract][Full Text] [Related]
5. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy.
La Noce M; Paino F; Mele L; Papaccio G; Regad T; Lombardi A; Papaccio F; Desiderio V; Tirino V
J Exp Clin Cancer Res; 2018 Dec; 37(1):296. PubMed ID: 30509303
[TBL] [Abstract][Full Text] [Related]
6. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
8. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents.
Xu W; Chen C; Xu R; Li Y; Hu R; Li Z; Zhu X
Biomed Pharmacother; 2018 Jun; 102():587-593. PubMed ID: 29597092
[TBL] [Abstract][Full Text] [Related]
10. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.
Chueh FS; Chen YY; Huang AC; Ho HC; Liao CL; Yang JS; Kuo CL; Chung JG
Environ Toxicol; 2014 Jan; 29(1):21-9. PubMed ID: 21922632
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells.
Paiva-Oliveira DI; Martins-Neves SR; Abrunhosa AJ; Fontes-Ribeiro C; Gomes CMF
Cancer Chemother Pharmacol; 2018 Jan; 81(1):49-63. PubMed ID: 29086064
[TBL] [Abstract][Full Text] [Related]
13. Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a.
Chang Y; Zhao Y; Gu W; Cao Y; Wang S; Pang J; Shi Y
Cell Physiol Biochem; 2015; 36(3):1186-96. PubMed ID: 26111756
[TBL] [Abstract][Full Text] [Related]
14. P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma.
He C; Sun Z; Hoffman RM; Yang Z; Jiang Y; Wang L; Hao Y
Anticancer Res; 2019 Apr; 39(4):1711-1718. PubMed ID: 30952710
[TBL] [Abstract][Full Text] [Related]
15. The HDAC inhibitor Vorinostat diminishes the in vitro metastatic behavior of Osteosarcoma cells.
Mu X; Brynien D; Weiss KR
Biomed Res Int; 2015; 2015():290368. PubMed ID: 25785263
[TBL] [Abstract][Full Text] [Related]
16. PAXX is a novel target to overcome resistance to doxorubicin and cisplatin in osteosarcoma.
Ma W; Yang L; Liu H; Chen P; Ren H; Ren P
Biochem Biophys Res Commun; 2020 Jan; 521(1):204-211. PubMed ID: 31640855
[TBL] [Abstract][Full Text] [Related]
17. LY2109761 inhibits metastasis and enhances chemosensitivity in osteosarcoma MG-63 cells.
Ren XF; Mu LP; Jiang YS; Wang L; Ma JF
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1182-90. PubMed ID: 25912577
[TBL] [Abstract][Full Text] [Related]
18. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
[TBL] [Abstract][Full Text] [Related]
19. Diosgenin exerts its tumor suppressive function via inhibition of Cdc20 in osteosarcoma cells.
Long C; Chen J; Zhou H; Jiang T; Fang X; Hou D; Liu P; Duan H
Cell Cycle; 2019 Feb; 18(3):346-358. PubMed ID: 30640578
[TBL] [Abstract][Full Text] [Related]
20. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]